Department of Neurosurgery, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Departments of Neurosurgery and Radiation Oncology, University of California, Los Angeles, California, USA.
World Neurosurg. 2021 Jan;145:323-333. doi: 10.1016/j.wneu.2020.08.205. Epub 2020 Sep 3.
Microsurgical callosotomy is a procedure still under debate and to best a palliative treatment for drug-resistant epilepsy. Unlike microsurgery, radiosurgical callosotomy is an underpracticed treatment option, with no definite account of its safety and outcome profile.
To evaluate the safety, efficacy, and complication profile of radiosurgical callosotomy in the literature.
PubMed, SCOPUS, Web of Science, and ResearchGate were reviewed for radiosurgery and callosotomy in the English language following PRISMA guidelines. The patient profile, radiosurgical parameters (dose and isodose), target volume, extent of radiosurgery (anterior third, half, or posterior third callosotomy), and seizure outcome were evaluated. We evaluated the role of radiosurgery as a primary or secondary treatment modality after microsurgery. A literature review was performed to identify the evidence of radiosurgery.
We identified 7 studies detailing 12 patients of mean age 22.8 years (range, 4-58 years) and a mean of 18.9 years of illness (range, 5-37 years). Five series performed Gamma Knife radiosurgery and 2 performed LINAC radiosurgery. The spectrum of seizures ranged from atonic seizures/drop attack (83%), generalized tonic-clonic seizures (75%), complex partial seizures (67%), absence seizures (50%), myoclonic seizures (33%), to focal seizures (16%). Four patients suffered from Lennox-Gastaut syndrome. The average seizure frequency in 11 patients was 297/month (range, 20/day to 15/month). Three patients became free of drop attacks and 2 free of generalized tonic-clonic seizures, and 1 became completely seizure free. The remaining patients continued to have seizures, albeit at a lower frequency. Complex partial seizures and myoclonic seizures were the least responsive seizure types to radiosurgical corpus callosotomy. All patients tolerated the procedure well. After radiosurgery, 3 patients developed symptomatic edema. The symptoms (headache, nausea, hemiparesis, and transient neurologic deficits) were controlled with a short course of steroids. Two patients needed redo radiosurgery (at the same target in 1 patient and complementary middle third callosotomy to previous anterior third callosotomy in another patient). There were no long-term complications.
Radiosurgery is a viable alternative to microsurgical callosotomy both as a primary and as a secondary treatment modality. It has a specific advantage of better neuropsychological outcomes with comparable seizure control. The neurosurgical community should adopt a more liberal approach with this indication.
显微胼胝体切开术仍是一种有争议的手术,是耐药性癫痫的姑息性治疗方法。与显微手术不同,放射外科胼胝体切开术是一种实践较少的治疗选择,其安全性和结果概况尚无明确记载。
在文献中评估放射外科胼胝体切开术的安全性、疗效和并发症情况。
根据 PRISMA 指南,在英语中在 PubMed、SCOPUS、Web of Science 和 ResearchGate 上搜索放射外科和胼胝体切开术。评估患者特征、放射外科参数(剂量和等剂量)、靶体积、放射外科范围(胼胝体前 1/3、1/2 或后 1/3 切开术)和癫痫发作结果。我们评估了放射外科作为显微手术后的主要或次要治疗方式的作用。进行文献复习以确定放射外科的证据。
我们确定了 7 项研究,详细介绍了 12 名平均年龄为 22.8 岁(范围 4-58 岁)和平均患病 18.9 年(范围 5-37 岁)的患者。5 项研究采用伽玛刀放射外科治疗,2 项研究采用直线加速器放射外科治疗。癫痫发作的范围从猝倒发作/跌倒发作(83%)、全面强直阵挛发作(75%)、复杂部分性发作(67%)、失神发作(50%)、肌阵挛发作(33%)到局灶性发作(16%)。4 例患者患有 Lennox-Gastaut 综合征。11 例患者的平均癫痫发作频率为 297/月(范围 20/天至 15/月)。3 例患者停止跌倒发作,2 例患者停止全面强直阵挛发作,1 例患者完全停止癫痫发作。其余患者仍有癫痫发作,尽管发作频率较低。复杂部分性发作和肌阵挛发作对放射外科胼胝体切开术的反应最差。所有患者均耐受良好。放射外科治疗后,3 例患者出现症状性水肿。通过短期类固醇治疗可控制症状(头痛、恶心、偏瘫和短暂性神经功能缺损)。2 例患者需要重新进行放射外科治疗(1 例患者在同一目标处,另 1 例患者在前 1/3 胼胝体切开术的基础上进行补充性中 1/3 胼胝体切开术)。没有长期并发症。
放射外科是显微胼胝体切开术的可行替代方法,无论是作为主要治疗方法还是作为次要治疗方法。它具有更好的神经心理学结果和类似的癫痫控制的特定优势。神经外科学会应该对这一适应证采取更自由的方法。